87 related articles for article (PubMed ID: 15302617)
1. Lipoprotein (a) and its immune complexes in dyslipidemic subjects.
Wang J; Zhang C; Chen D; Liu X; Feng X
Clin Biochem; 2004 Aug; 37(8):710-3. PubMed ID: 15302617
[TBL] [Abstract][Full Text] [Related]
2. Plasma oxidized lipoprotein(a) and its immune complexes are present in newborns and children.
Wang J; Niu D; Meng Y; Han A; Li K; Zhang C
Clin Chim Acta; 2009 Sep; 407(1-2):1-5. PubMed ID: 19545557
[TBL] [Abstract][Full Text] [Related]
3. Detection of IgG-bound lipoprotein(a) immune complexes in patients with coronary heart disease.
Wang J; Qiang H; Zhang C; Liu X; Chen D; Wang S
Clin Chim Acta; 2003 Jan; 327(1-2):115-22. PubMed ID: 12482626
[TBL] [Abstract][Full Text] [Related]
4. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
[TBL] [Abstract][Full Text] [Related]
5. Native, oxidized lipoprotein(a) and lipoprotein(a) immune complex in patients with active and inactive rheumatoid arthritis: plasma concentrations and relationship to inflammation.
Wang J; Hu B; Kong L; Cai H; Zhang C
Clin Chim Acta; 2008 Apr; 390(1-2):67-71. PubMed ID: 18237550
[TBL] [Abstract][Full Text] [Related]
6. Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome.
Berneis K; Rizzo M; Hersberger M; Rini GB; Di Fede G; Pepe I; Spinas GA; Carmina E
Int J Clin Pract; 2009 Jan; 63(1):56-62. PubMed ID: 19125993
[TBL] [Abstract][Full Text] [Related]
7. CETP and oxidized LDL levels increase in dyslipidemic subjects.
Wang J; Gu Q; Li K; Zhang C
Clin Biochem; 2007 Sep; 40(13-14):995-9. PubMed ID: 17658505
[TBL] [Abstract][Full Text] [Related]
8. The relationship of TFPI, Lp(a), and oxidized LDL antibody levels in patients with coronary artery disease.
Bilgen D; Sönmez H; Ekmekçi H; Ulutin T; Oztürk Z; Kökoğlu E; Bayram C; Soner A; Domaniç N
Clin Biochem; 2005 Jan; 38(1):92-6. PubMed ID: 15607324
[TBL] [Abstract][Full Text] [Related]
9. Development of new enzyme-linked immunosorbent assay for oxidized lipoprotein(a) by using purified human oxidized lipoprotein(a) autoantibodies as capture antibody.
Wang J; Zhang C; Gong J; Zhu Y; Fu L; Wang X; Li K
Clin Chim Acta; 2007 Oct; 385(1-2):73-8. PubMed ID: 17719023
[TBL] [Abstract][Full Text] [Related]
10. Differential effect of hypolipidemic drugs on lipoprotein-associated phospholipase A2.
Saougos VG; Tambaki AP; Kalogirou M; Kostapanos M; Gazi IF; Wolfert RL; Elisaf M; Tselepis AD
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2236-43. PubMed ID: 17656665
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein (a) in patients with psoriasis: associations with lipid profiles and disease severity.
Pietrzak A; Kadzielewski J; Janowski K; Roliński J; Krasowska D; Chodorowska G; Paszkowski T; Kapeć E; Jastrzebska I; Tabarkiewicz J; Lotti T
Int J Dermatol; 2009 Apr; 48(4):379-87. PubMed ID: 19335423
[TBL] [Abstract][Full Text] [Related]
12. Oxidized low-density lipoprotein in children with familial hypercholesterolemia and unaffected siblings: effect of pravastatin.
Rodenburg J; Vissers MN; Wiegman A; Miller ER; Ridker PM; Witztum JL; Kastelein JJ; Tsimikas S
J Am Coll Cardiol; 2006 May; 47(9):1803-10. PubMed ID: 16682304
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction.
Gaeta G; Cuomo S; Capozzi G; Foglia MC; Barra S; Madrid A; Stornaiuolo V; Trevisan M
Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):492-6. PubMed ID: 17962002
[TBL] [Abstract][Full Text] [Related]
14. High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial.
Tsimikas S; Witztum JL; Miller ER; Sasiela WJ; Szarek M; Olsson AG; Schwartz GG;
Circulation; 2004 Sep; 110(11):1406-12. PubMed ID: 15353498
[TBL] [Abstract][Full Text] [Related]
15. [Postprandial changes of blood lipid after ordinary Chinese diet and the influencing factors thereof].
Fu ZF; Liu ML
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):260-2. PubMed ID: 19552844
[TBL] [Abstract][Full Text] [Related]
16. Relationship between plasma lipid concentrations and HDL subclasses.
Yang Y; Yan B; Fu M; Xu Y; Tian Y
Clin Chim Acta; 2005 Apr; 354(1-2):49-58. PubMed ID: 15748599
[TBL] [Abstract][Full Text] [Related]
17. Potential atherogenic roles of lipids, lipoprotein(a) and lipid peroxidation in preeclampsia.
Bayhan G; Koçyigit Y; Atamer A; Atamer Y; Akkus Z
Gynecol Endocrinol; 2005 Jul; 21(1):1-6. PubMed ID: 16048794
[TBL] [Abstract][Full Text] [Related]
18. Lp(a) and plasma triglyceride-rich lipoproteins.
McConathy WJ; Trieu VN; Klör HU; Corder CN
Klin Wochenschr; 1990; 68 Suppl 22():117-9. PubMed ID: 2150869
[TBL] [Abstract][Full Text] [Related]
19. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
20. A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemia.
Kostapanos MS; Milionis HJ; Filippatos TD; Nakou ES; Bairaktari ET; Tselepis AD; Elisaf MS
Clin Ther; 2007 Jul; 29(7):1403-14. PubMed ID: 17825691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]